Skip to main content

Forum on Drug Discovery, Development, and Translation 2019 Annual Report (2020) / Chapter Skim
Currently Skimming:

Timeline
Pages 24-28

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 24...
... 2018 | March 6–7 Workshop Series: Examining the Impact of Real-World Evidence on Medical Product Development -- 2015 | January 20–21 Workshop: Financial Incentives to Workshop 2: Practical Approaches | March 19–20 Forum Support Unmet Medical Needs for Nervous System Disorders Meeting #39 | May 9 Workshop: Advancing the Science of Patient (in collaboration with the Forum on Neuroscience and Nervous Input in Medical Product R&D: Towards a Research Agenda | System Disorders) | March 17–18 Forum Meeting #30 | March July 17–18 Workshop Series: Examining the Impact of Real- 26–27 Workshop: Rapid Medical Countermeasure Response to World Evidence on Medical Product Development -- Workshop 3: Infectious Diseases: Enabling Sustainable Capabilities Through Application | July 18 Forum Meeting #40 | October 3–4 Forum Ongoing Public- and Private-Sector Partnerships (in collaboration Meeting #41 | November 28–29 Workshop: Virtual Clinical Trials: with the Forum on Medical and Public Health Preparedness for Challenges and Opportunities Disasters and Emergencies)
Read the entire page →
From page 25...
... | June Medical Product Development | June 3 Forum Meeting #25 | 28–29 Forum Meeting #19 | July 12 Workshop Summary Release: October 28–29 Forum Meeting #26 The Emerging Threat of Multidrug-Resistant Tuberculosis: Global and Local Challenges and Solutions (Durban, South Africa) | 2012 | March 13–14 Forum Meeting #21 | June 4–5 Workshop: September 20–21 Workshop: Strengthening a Workforce for Maximizing the Goals of the Cures Acceleration Network to Innovative Regulatory Science in Therapeutics Development | Accelerate the Development of New Drugs and Diagnostics October 4–5 Forum Meeting #20 | November 7–8 Workshop: | June 5 Forum Meeting #22 | July 31–August 1 Workshop: Envisioning a Transformed Clinical Trials Enterprise in the Developing and Strengthening the Global Supply Chain for United States: Establishing an Agenda for 2020 | November 15 Second-Line Drugs for Multidrug-Resistant Tuberculosis | Workshop Summary Release: The New Profile of Drug-Resistant October 4–5 Workshop: Sharing Clinical Research Data (in Tuberculosis: A Global and Local Perspective (Moscow, Russia)
Read the entire page →
From page 26...
... | October 15–16 Forum Meeting #8 | 2009 | February 23 Capitol Hill Briefing: Growing Threat of November 30 Discussion Series: A Conversation with Tony Fauci Drug-Resistant Tuberculosis | March 13 Discussion Series: FDA Community Update on Personalized Medicine and the Genetic 2006 | March 28–29 Forum Meeting #4 | May 30–31 Workshop: Basis of Adverse Events | April 27 Workshop: Streamlining Understanding the Benefits and Risks of Pharmaceuticals | Clinical Trial and Material Transfer Negotiations | April 27–28 June 13 Workshop: Addressing the Barriers to Pediatric Drug Forum Meeting #12 | July 10 Symposium: Drug Regulation with Development | June 27–28 Forum Meeting #5 | October 24–25 FDA Commissioner Peggy Hamburg and Forum Meeting #13 Forum Meeting #6 | September 2 Discussion Series: FDA Community Update: Improving the Science of Drug Safety | October 7–8 Workshop: 2005 | March 28–29 Forum Meeting #4 | May 30–31 Workshop: Transforming Clinical Research in the United States | October Understanding the Benefits and Risks of Pharmaceuticals | 15–16 Forum Meeting #14 June 13 Workshop: Addressing the Barriers to Pediatric Drug Development | June 27–28 Forum Meeting #5 | October 24–25 2008 | February 20 Discussion Series: Comparative Forum Meeting #6 Effectiveness | February 20–21 Forum Meeting #9 | April 21 Discussion Series: Science at FDA: Challenges and Opportunities 2002–2004 | Clinical Research Roundtable, predecessor to the Forum 26
Read the entire page →
From page 27...
... Associate Program Officer Melvin Joppy Senior Program Assistant National Academies staff supporting the Forum in 2019 (from left to right) : Jeanay BOARD ON HEALTH SCIENCES POLICY Butler, Sylvia Ncha, Anna I
Read the entire page →
From page 28...
... To supplement the Engineering, and Medicine to provide independent, objective analysis and perspectives and expertise of its members, the Forum also advice to the nation and conduct other activities to solve complex problems and holds public workshops to engage a wide range of experts, inform public policy decisions. The National Academies also encourage education members of the public, and the policy community.
Read the entire page →

Key Terms

  • policy forum
  • cancer policy
  • precision health
  • medical product
  • drug discovery

  • workshop summary
  • sciences policy
  • drug safety
  • sharing clinical
  • health preparedness

  • global supply
  • pharmaceutical products
  • south africa
  • communicating uncertainty
  • supply chain

  • regulatory science
  • emerging threat
  • mount sinai
  • acceleration network
  • virtual clinical

  • please visit
  • regulating biomedical
  • trials enterprise
  • inform public
  • clinical trials

  • transparent reporting
  • potential solutions
  • knowledge generation
  • camilo javier
  • public workshops


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.